Skip to content

Author

Xiao-Mei He

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

NK Cell Technology for Tumour Treatment: Advances, Advantages, Challenges, and Clinical Prospects

The natural cytotoxic properties of natural killer (NK) cells together with their suitability for genetic modification have attracted increasing interest in tumour immunotherapy. This review evaluates how NK cell-based therapies have developed, with particular attention to chimeric antigen receptor (CAR)-NK technology,...

Xiao-Mei He · 0 citations
Open access Sep 2026

Single-cell and bulk transcriptomic integration identifies a high-CNV, dark-zone-enriched malignant cell state associated with adverse prognosis in GCB-DLBCL.

BACKGROUND Germinal centre B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) generally has a better prognosis than activated B-cell-like DLBCL, yet a clinically significant subset of patients still develops aggressive disease, suggesting marked malignant cellular heterogeneity within this subtype. This study aimed...

Jia-Ning Wang, Xiu-Ying Xiang, Xiao-Mei He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.